# ST250 as a Therapeutic Option for Head & Neck Reconstruction

> **NCT06543823** · PHASE1,PHASE2 · RECRUITING · sponsor: **Alaa Emara** · enrollment: 60 (estimated)

## Conditions studied

- Tonsillitis

## Interventions

- **DEVICE:** SupraTHEL 250
- **OTHER:** Comparator

## Key facts

- **NCT ID:** NCT06543823
- **Lead sponsor:** Alaa Emara
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-30
- **Primary completion:** 2025-12
- **Final completion:** 2026-02
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06543823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06543823, "ST250 as a Therapeutic Option for Head & Neck Reconstruction". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06543823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*